Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe Emergency Use Authorization (EUA) Of LAGEVRIO™ (molnupiravir) capsules For Coronavirus Disease 2019 (COVID-19) What is the most important information I should
Swallow the capsule whole with a glass of water
Molnupiravir has received EUA in 3 countries for treatment of mild-moderate COVID-19 in certain adults who are at high risk for progression to severe COVID-19
Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19
Molnupiravir is more expensive, at $712 for a 5-day course, compared with
Because NAFLD is associated with severe COVID-19, effective management of COVID-19 in this high-risk population is important
Here’s what you need to know about the updated Novavax COVID vaccine: It’s an adjuvanted, protein-based
Immunizations are by appointment only